Figure 1From: Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease Change in plasma amyloid-β peptide levels. Abeta, Amyloid-β; LY100mg, Semagacestat 100 mg; LY140mg, Semagacestat 140 mg.Back to article page